Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003641
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
1999-11-01
Brief Title:
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Sponsor:
ECOG-ACRIN Cancer Research Group
Organization:
Eastern Cooperative Oncology Group
Organization Data
Organization:
Eastern Cooperative Oncology Group
Class:
NETWORK
Study ID:
E1697
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ECOG-ACRIN Cancer Research Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Childrens Oncology Group | NETWORK |
| National Cancer Institute NCI | NIH |
| SWOG Cancer Research Network | NETWORK |
| Cancer and Leukemia Group B | NETWORK |
| NCIC Clinical Trials Group | NETWORK |